People: Apple Inc (AAPL.O)

AAPL.O on Nasdaq

97.19USD
23 Jul 2014
Price Change (% chg)

$2.47 (+2.61%)
Prev Close
$94.72
Open
$95.42
Day's High
$97.88
Day's Low
$95.17
Volume
92,917,719
Avg. Vol
63,868,130
52-wk High
$97.88
52-wk Low
$59.82

Search Stocks

Levinson, Arthur 

Brief Biography

Dr. Arthur D. Levinson is an Independent Chairman of the Board of Apple Inc. Arthur Levinson has been Chairman of Genentech, Inc. (“Genentech”) since September 1999, and a member of the Roche Holding Ltd. board of directors since March 2010. Dr. Levinson previously served as Chief Executive Officer of Genentech from July 1995 to April 2009. Dr. Levinson has also served as a director of F. Hoffman-La Roche Ltd since March 2010, where he serves on the Remuneration Committee, and in September 2013, was named the Chief Executive Officer of Calico LLC, a company focused on health, aging and well-being. Dr. Levinson is also Chairman of the Board of Amyris, Inc., and a director of NGM Biopharmaceuticals, Inc., and the Broad Institute of Harvard and MIT. Dr. Levinson also serves on the Board of Scientific Consultants of the Memorial Sloan-Kettering Cancer Center, on the Industrial Advisory Board of the California Institute for Quantitative Biomedical Research, on the Advisory Council for the Princeton University Department of Molecular Biology, and on the Advisory Council for the Lewis-Sigler Institute for Integrative Genomics. From May 2009 to September 2013, Dr. Levinson served as an advisor to Genentech’s Research and Early Development center, and as a member of Genentech’s external advisory group, the Scientific Resource Board. Dr. Levinson previously served as a director of Google Inc. from April 2004 until October 2009. Among other qualifications, Dr. Levinson brings to the Board executive leadership experience, including his service as a chairman of a public company, along with extensive financial expertise and brand marketing experience.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Arthur Levinson

--

Timothy Cook

4,252,730

Luca Maestri

--

D. Sewell

68,989,800

Philip Schiller

11,677,200

Eduardo Cue

2,647,100
As Of 27 Sep 2013
Search Stocks